Replies to post #12997 on Generex Biotechnology Corp. (fka GNBTQ)

[myjo]

Glad to know that 0.29$ stock price is no longer acceptable. Point is what is he doing to get stock price up? Why does he continue to make deals with toxic financiers rewarding them no-restriction bargain basement prices GNBT stocks to sell in open market? Point is does market believe in him such that he has what it takes to bring GNBT stock price up? Right now market absolutely doesn’t believe in him at all. Last conference call, the moment he started talking on conference call, GNBT stock started dropping like a rock.

[docj]

Listen in and find out:

Generex Biotechnology Announces Investor Conference Call Scheduled for
Friday February 5, 2021 at 9:00 AM
MIRAMAR, FL, January 08, 2021/ -- Generex Biotechnology Corporation
(www.generex.com) (OTCQB:GNBT) today announced that it will hold an investor
conference call on Friday February 5, 2021 at 9:00 AM.
Joseph Moscato, Generex President & Chief Executive Officer stated: “I am excited to
give our first shareholder conference call to update investors about the development of
our Ii-Key complete vaccine against the SARS-CoV-2 coronavirus that continues to
ravage the world. We have completed our ex vivo human trial of COVID-19 patient
samples and can confirm that the results of the T cell activation and antibody screen
have enabled us to select Ii-Key-SARS-CoV-2 epitopes for our vaccine formulation. I will
provide an update on these results as well as the results of our ongoing immunogenicity
study that will confirm the commercial viability of our Ii-Key vaccine. In addition, I will
update everyone on our progress and timing on the NuGenerex Immuno-Oncology
Nasdaq listing now that our third-party valuation analysis has been completed with a
value estimated at over $500 million. This third-party valuation report is the last piece of
information required to enable us to set the price per share to meet the standards for
the Nasdaq. I will also provide a complete corporate update including discussions of our
subsidiaries”

[Jimmy Joe]

That makes me happy knowing his interest are aligned with mine, moreso than ever. I know he has put a huge amount of his personal money into Generex and taken a pittance of salary for his 4 years of work.

docj, that speaks to his putting the investors first. Part of my attraction to Generex was because Joe wanted to award shareholders who were patient, and who lost money over the years.

The other attractions were up listing, NGIO, and their multiple platforms.

I like that fact that they are focused on COVID right now. They need to stay focused. Am impressed with the way this company is being run, despite what detractors post. Patience is a key component with any investment.

I see good things coming..... February 5th will give investors the read between the lines information. Looking forward to it.

Everyone, stay safe out there. This virus is no joke.